<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0525">
 <label>105</label>
 <element-citation publication-type="journal" id="h0525">
  <person-group person-group-type="author">
   <name>
    <surname>Yamaya</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nishimura</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Kikuchi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nagatomi</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Protease inhibitors: candidate drugs to inhibit severe acute respiratory syndrome Coronavirus 2 replication</article-title>
  <source>Tohoku J. Exp. Med.</source>
  <volume>251</volume>
  <year>2020</year>
  <fpage>27</fpage>
  <lpage>30</lpage>
  <pub-id pub-id-type="doi">10.1620/tjem.251.27</pub-id>
  <pub-id pub-id-type="pmid">32448818</pub-id>
 </element-citation>
</ref>
